Paving new roads toward the advancement of broad‐spectrum antiviral agents
Journal of Medical Virology · 2024
DOI: 10.1002/jmv.29369 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Ruikun Du und 3 weiteren Autor:innen. Beteiligte Einrichtung: Innovative Institute of Chinese Medicine and Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Antiviral Agents, Virus Diseases. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 77 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jinan Independent Training Innovative Team, Open Research Fund Program of the State Key Laboratory of Virology of China.
Abstract (Originalsprache)
Broad‐spectrum antivirals (BSAs) have the advantageous property of being effective against a wide range of viruses with a single drug, offering a promising therapeutic solution for the largely unmet need in treating both existing and emerging viral infections. In this review, we summarize the current strategies for the development of novel BSAs, focusing on either targeting the commonalities during the replication of multiple viruses or the systemic immunity of humans. In comparison to BSAs that target viral replication, these immuno‐modulatory agents possess an expanded spectrum of antiviral activity. However, antiviral immunity is a double‐edged sword, and maintaining immune homeostasis ultimately dictates the health status of hosts during viral infections. Therefore, establishing an ideal goal for immuno‐modulation in antiviral interventions is crucial. Herein we propose a bionic approach for immuno‐modulation inspired by mimicking bats, which possess a more robust immune system for combating viral invasions, compared to humans. In addition, we discuss an empirical approach to treat diverse viral infections using traditional Chinese medicines (TCMs), mainly through bidirectional immuno‐modulation to restore the disrupted homeostasis. Advancing our understanding of both the immune system of bats and the mechanisms underlying antiviral TCMs will significantly contribute to the future development of novel BSAs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Innovative Institute of Chinese Medicine and Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
- Qingdao Academy of Chinese Medical Sciences, Shandong University of Traditional Chinese Medicine, Qingdao, China.
- Department of Microbiology and Immunology, University of Illinois at Chicago, Chicago, Illinois, USA.
ORCID-Profile: Ruikun Du, Jazmin G Achi
Förderung
- National Natural Science Foundation of China
- Jinan Independent Training Innovative Team
- Open Research Fund Program of the State Key Laboratory of Virology of China
Zitieren
APA
Du, R., Achi, J. G., Cui, Q., & Rong, L. (2024). Paving new roads toward the advancement of broad‐spectrum antiviral agents. Journal of Medical Virology. https://doi.org/10.1002/jmv.29369
Vancouver
Du R, Achi JG, Cui Q, Rong L. Paving new roads toward the advancement of broad‐spectrum antiviral agents. Journal of Medical Virology. 2024. doi:10.1002/jmv.29369
BibTeX
@article{Du2024,
author = {Du, Ruikun and Achi, Jazmin G and Cui, Qinghua and Rong, Lijun},
title = {Paving new roads toward the advancement of broad‐spectrum antiviral agents},
journal = {Journal of Medical Virology},
year = {2024},
doi = {10.1002/jmv.29369}
}
EUVIMED